TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Stockholm Vaccin-Lättakut AB
Closing information (x1000 NOK)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
4,387
|
4,637
|
3,302 |
| Financial expenses |
0
|
1
|
1 |
| Earnings before taxes |
-639
|
-327
|
-314 |
| EBITDA |
-639
|
-323
|
-310 |
| Total assets |
1,096
|
2,048
|
1,968 |
| Current assets |
1,082
|
2,031
|
1,949 |
| Current liabilities |
377
|
648
|
380 |
| Equity capital |
719
|
1,401
|
1,589 |
| - share capital |
101
|
104
|
95 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
65.6%
|
68.4%
|
80.7% |
| Turnover per employee |
1,462
|
1,546
|
1,101 |
| Profit as a percentage of turnover |
-14.6%
|
-7.1%
|
-9.5% |
| Return on assets (ROA) |
-58.3%
|
-15.9%
|
-15.9% |
| Current ratio |
287.0%
|
313.4%
|
512.9% |
| Return on equity (ROE) |
-88.9%
|
-23.3%
|
-19.8% |
| Change turnover |
-110
|
1,047
|
-473 |
| Change turnover % |
-2%
|
29%
|
-13% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.